Admission Date:  [**2128-3-23**]              Discharge Date:   [**2128-4-10**]  Date of Birth:  [**2047-3-11**]             Sex:   M  Service: SURGERY  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 668**] Chief Complaint: hilar mass in segment IV of liver  Major Surgical or Invasive Procedure: [**2128-3-23**] Diagnostic laparoscopy conversion to exploratory laparotomy, common bile duct excision Roux-en-Y hepaticojejunostomy, intraoperative ultrasound  History of Present Illness: 81 y.o.
After extensive workup was performed, he finally presents for exploratory laparotomy for resection of hilar mass in segment IV of liver.
Past Medical History: CAD GERD, HTN myelodysplastic syndrome with refractory anemia, On Epoietin   Social History: Lives in own home with wife Social ETOH non-smoker Retired chemical engineer   Family History: Non-Contributory  Pertinent Results: On Admission: [**2128-3-23**] WBC-36.0*# RBC-3.05* Hgb-10.7* Hct-31.8* MCV-104* MCH-35.1* MCHC-33.7 RDW-14.9 Plt Ct-347 PT-14.7* INR(PT)-1.3* Glucose-139* UreaN-15 Creat-0.7 Na-136 K-4.1 Cl-108 HCO3-22 AnGap-10 ALT-120* AST-131* AlkPhos-733* TotBili-2.4*  CK(CPK)-95 Lipase-14 [**2128-4-1**]  TSH-1.5 [**2128-4-1**]  T4-6.1 .
ON DISCHARGE: [**2128-4-10**] 05:35AM BLOOD WBC-11.9* RBC-3.23* Hgb-10.2* Hct-29.1* MCV-90 MCH-31.6 MCHC-35.1* RDW-17.4* Plt Ct-184 [**2128-4-9**] 08:14PM BLOOD Hct-30.6* [**2128-4-9**] 12:50PM BLOOD WBC-13.3* RBC-3.23* Hgb-10.5* Hct-29.2* MCV-90 MCH-32.5* MCHC-36.0* RDW-17.3* Plt Ct-178 [**2128-4-9**] 05:39AM BLOOD PT-11.1 PTT-24.8 INR(PT)-0.9 [**2128-4-10**] 05:35AM BLOOD Glucose-77 UreaN-16 Creat-0.8 Na-131* K-3.9 Cl-101 HCO3-24 AnGap-10 [**2128-4-7**] 04:33AM BLOOD ALT-20 AST-21 AlkPhos-230* TotBili-0.9 [**2128-4-4**] 02:21AM BLOOD Lipase-53 [**2128-4-9**] 05:39AM BLOOD Calcium-7.5* Phos-2.7 Mg-1.8 .
RADIOLOGY  Final Report CT ABDOMEN W/CONTRAST  [**2128-4-9**] 6:28 PM CT ABDOMEN W/CONTRAST; CT PELVIS W/CONTRAST Reason: PO AND IV CONTRAST; eval for enterocutaneous fistula or pseu Field of view: 39 Contrast: [**Hospital 13288**] [**Hospital 93**] MEDICAL CONDITION: 80M s/p exploratory laparoscopy, roux-en-y hepaticojejunostomy, cholecystectomy for unresectable cholangioCA s/p wound infection with open wound.
TECHNIQUE: MDCT-acquired axial imaging from the lung bases to the pubic symphysis after administration of oral and intravenous contrast.
CT OF THE ABDOMEN WITH IV CONTRAST: Visualized lung bases demonstrate small bilateral pleural effusions and adjacent atelectasis.
CT OF THE PELVIS WITH IV CONTRAST: The rectum, sigmoid colon and pelvic loops of bowel are unremarkable.
Intraoperative ultrasound was performed which demonstrated a large mass in the medial segment of the left lobe.
An End-to-side hepaticojejunostomy was done over the 10-French [**Location (un) 3825**] stents which were changed out from the pigtail catheters.
[**Initials (NamePattern4) **] [**Last Name (NamePattern4) 406**] drain was placed near this anastomosis.
On pod 3 he experienced new onset AFIB requiring IV lopressor for rate control.
Urine output was on the low side averaging 10-25cc/hour.
On [**3-29**] a tube cholangiogram was done demonstrating right moderate narrowing at the anastomosis, likely representing post-operative edema without anastomotic leak.
The Left cholangiogram demonstrated diffuse ductal dilatation with lack of opacification of the central ducts and retraction and malpositioning of the left-sided biliary catheter.
A CT was done to evaluate for collection.
BB, CCB and neo were used to keep map >65.
He converted back to SR. An echo showed  LVEF of >55%.
The next day he received 2 units of PRBC for hct of 24.3.
Heart rate was in 80's in afib.
A tagged RBC study was done revealing no active GI bleeding.
EGD revealed no upper GI bleed.
A CT scan was performed on [**2128-4-9**] for determine a possible enterocutanous fistula, none was detected.
Serial hcts did not demonstrate a acute decrease in his hct and he was deemed stable for discharge home with transition to hospice care on [**2128-4-10**].
Medications on Admission: Atenolol 25mg',Ranitidine 150 mg PO BID, Lisinopril 20mg', Cholestyramine 4gm [**Hospital1 **], ASA 81mg x 2 QD (CLARIFY) .
Release 24 hr Sig: One (1) Capsule, Sust.
Release 24 hr PO HS (at bedtime).
Followup Instructions: Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) 1330**], MD Phone:[**Telephone/Fax (1) 673**] Date/Time:[**2128-4-16**] 2:10 .
